Clarus Therapeutics Holdings, Inc. Announces Plan for

Bidding process and auction for JATENZO (testosterone undecanoate capsules; C-III) projected to conclude late October 2022...

Related Keywords

Delaware ,United States ,Raymond James ,Steve Bourne ,Geoffrey Richards ,Lawrence Perkins ,Robert Dudley ,Us Bankruptcy Court ,Potter Anderson Corroon ,Sierra Constellation Partners ,District Of Delaware The Court ,Exchange Commission ,Raymond James Associates Inc ,Clarus Therapeutics Inc ,Goodwin Procter ,Clarus Therapeutics Holdings Inc ,Stretto Inc ,Therapeutics Holdings ,Clarus Therapeutics ,Bankruptcy Code ,Capital Structure Advisory ,Claru Board ,Potter Anderson ,Chief Restructuring Officer ,Simon Wein ,Clarus Therapeutics Holdings ,Nasdaq Crxt ,Nc ,